All
Expert Gives an Overview of New Drugs to Treat AML
October 9th 2017For the past four decades, there have been few advances in the treatment field of acute myeloid leukemia (AML). However, in the year 2017, there have been four new drugs approved by the FDA to treat the disease, with even more promising agents in the pipeline.
Breast Cancer Death Rates Drop, But Racial Disparities Remain Among Patients
October 4th 2017Improved treatment and early detection means fewer women in the United States are dying from breast cancer, according to a study released by the American Cancer Society (ACS) that examined trends in the disease.
Drug Pair Benefits Patients With Melanoma Who Progressed on Prior Therapy
October 3rd 2017Combination therapy of Opdivo (nivolumab) and LAG-3 inhibitor relatlimab (BMS-986016) benefitted half of the patients with melanoma who previously progressed on an anti-PD-1 or anti-PD-L1 therapy, according to recent results from a dose-expansion study.